Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?

Table 3 Association of T2DM complications and comorbidities with mortality among study subjects

Variables	Mortality Outcome		Chi-square p-value	cOR(95%CI)	p-value
Variables	Alive	Dead	Chi-square p-value	cOR(95%CI)	p-value
Cardiovascular disorders
Absent	227(87.98)	31(12.02)	0.419	Ref
Present	64(91.43)	6(8.57)		0.68(0.27–1.72)	0.421
Nephropathy
Absent	258(90.85)	26(9.15)	0.002	Ref
Present	33(75.00)	11(25.00)		3.31(1.50–7.31)	0.003
Neuropathy
Absent	290(88.96)	36(11.04)	0.085	Ref
Present	1(50.00)	1(50.00)		8.06(0.49-131.59)	0.143
Foot Ulcer
Absent	279(88.57)	36(11.43)	1.000	Ref
Present	12(92.31)	1(7.69)		0.65(0.08–5.11)	0.679
Diabetic Ketoacidosis
Absent	240(87.91)	33(12.09)	0.303	Ref
Present	51(92.73)	4(7.27)		0.57(0.19–1.68)	0.309
Hyperosmolarity coma
Absent	284(88.75)	36(11.25)	1.000	Ref
Present	7(87.50)	1(12.50)		1.13(0.13–9.42)	0.912
Hyperosmolarity without coma
Absent	282(88.96)	35(11.04)	0.358	Ref
Present	9(81.82)	2(18.18)		1.79(0.37–8.62)	0.468
Other conditions
Skin Infection
Absent	286(88.54)	37(11.46)	1.000
Present	5(100.00)	0(0.00)		-
Sickle Cell
Absent	291(88.99)	36(11.01)	0.113
Present	0(0.00)	1(100.00)		-
Sepsis
Absent	291(89.26)	35(10.74)	0.012	-
Present	0(0.00)	2(100.00)
Urinary Tract Infection
Absent	282(88.40)	37(11.60)	0.605
Present	9(100.00)	0(0.00)		-
Pneumonia
Absent	286(88.82)	36(11.18)	0.515	Ref
Present	5(83.33)	1(16.67)		1.59(0.18–13.98)	0.676

ISSN: 1472-6823